Cleveland Clinic to suspend Natrecor

Cardiologists at the Cleveland Clinic have voted to "either ban or severely curtail" use of the heart drug Natrecor after two recently published studies showed it involves serious risks. A panel will vote today to decide if the ban should be a full one. Natrecor is manufactured by Johnson & Johnson. The news is likely to lead to similar actions at cardiology departments across the country. Johnson & Johnson had argued the drug should remain on the market, and had proposed labeling changes to notify physicians of potential risks.

For more on Natrecor:
- see this story from The New York Times

Post a comment